サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1596062

前臨床CROの世界市場：2033年までの機会と戦略

Preclinical CRO Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 323 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
前臨床CROの世界市場：2033年までの機会と戦略
出版日: 2024年11月21日
発行: The Business Research Company
ページ情報: 英文 323 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の前臨床CRO市場は2018年に37億5,582万米ドルと評価され、2023年までCAGR6.0％以上で成長しました。

個別化医療への注目の高まり

個別化医療への注目の高まりが、歴史的な期間における前臨床CRO市場の成長を促進しました。個別化医療では、複数のバイオマーカーや遺伝子変異の評価を含む複雑な試験デザインが頻繁に必要とされます。前臨床CROは、このような複雑な試験を管理するために必要な専門知識を有し、個別化治療アプローチの特定のニーズに合わせた実験の設計と実施に特化したスキルを提供します。例えば、2022年10月、米国を拠点とし、科学者、患者、医療提供者を代表する組織である個別化医療連合（Personalized Medicine Coalition）によると、複数のタイプのがん、遺伝的希少疾患、さまざまな慢性疾患や感染症の患者向けに、75,000を超える遺伝子検査製品と300の個別化医薬品が市販されていると推定されています。さらに、2022年には米国食品医薬品局による新薬承認の34％を個別化医薬品が占めると推定され、過去8年間はいずれも承認の25％以上を個別化医薬品が占めてきました。従って、個別化医療への注目の高まりが、歴史的な期間における前臨床CRO市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 前臨床CRO - 市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 前臨床CRO市場定義とセグメンテーション
  • 市場セグメンテーション：サービス別
    • 生体分析とDMPK研究
    • 毒性試験
    • 化合物管理
    • 化学
    • 安全性薬理学
    • その他サービス
  • 市場セグメンテーション：タイプ別
    • 患者由来オルガノイド（PDO）モデル
    • 患者由来異種移植モデル
  • 市場セグメンテーション：動物モデル別
    • 小動物モデル
    • 大型動物モデル
  • 市場セグメンテーション：モデルシステム別
    • In vivo
    • In vitro（体外）
  • 市場セグメンテーション：エンドユーザー別
    • バイオ医薬品企業
    • 政府機関および学術機関
    • 医療機器企業
    • その他のエンドユーザー

第7章 主要な市場動向

  • エンドツーエンドのサポートのための包括的な臨床試験サービスユニットのイントロダクション
  • 革新的なCROソリューションは、従来のサービスと最先端のテクノロジーを組み合わせています
  • 高度なAIプラットフォームで医薬品開発パイプラインを加速

第8章 前臨床CRO市場：マクロ経済シナリオ

  • COVID-19の影響：前臨床CRO市場
  • ウクライナ戦争の影響：前臨床CRO市場
  • 高インフレの影響：前臨床CRO市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018年～2023年
    • 市場促進要因、2018年～2023年
    • 市場抑制要因、2018年～2023年
  • 市場成長予測、2023年～2028年、2033年
    • 市場促進要因、2023年～2028年
    • 市場抑制要因、2023年～2028年

第10章 世界の前臨床CRO市場：セグメンテーション

  • 世界の前臨床CRO市場：サービス別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の前臨床CRO市場：タイプ別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の前臨床CRO市場：動物モデル別：、実績と予測、2018年～2023年、2028年、2033年
  • 世界の前臨床CRO市場：モデルシステム別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の前臨床CRO市場：エンドユーザー別、実績と予測、2018年～2023年、2028年、2033年

第11章 前臨床CRO市場：地域・国別分析

  • 世界の前臨床CRO市場：地域別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の前臨床CRO市場：国別、実績と予測、2018年～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.（Pharmaceutical Product Development（PPD））
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings（Covance Inc.）
  • ICON Plc

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Selvita S.A. Acquired PozLab
  • Veeda Clinical Research Limited Acquired Heads
  • Iuvo Bioscience Acquired Promedica International
  • ProPharma Group Acquired Clinres Farmacija
  • Alliance Pharmaceuticals Limited Acquired Denali Medpharma
  • ETAP-Lab Acquired SYNCROSOME
  • ERBC Group Acquired Oncofactory
  • Novotech Acquired EastHORN
  • BioIVT, LLC Acquired XenoTech, LLC
  • Asahi Kasei Medical Co. Ltd Acquired Bionova Scientific LLC
  • Altasciences Acquired Sinclair Research
  • Thermo Fisher Scientific Inc. Acquired PPD Inc.
  • Laboratory Corporation of America Holdings（LabCorp）Acquired Toxikon Corporation

第23章 機会と戦略

  • 世界の前臨床CRO市場、2028年：新たな機会を提供する国
  • 世界の前臨床CRO市場、2028年：新たな機会を提供するセグメント
  • 世界の前臨床CRO市場、2028年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 前臨床CRO市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1373

A preclinical contract research organization (CRO) provides outsourced research services to pharmaceutical, biotechnology and medical device companies, as well as academic institutions, primarily during the early stages of drug discovery and development.

The preclinical CRO market consists of sales, by entities (organizations, sole traders and partnerships), of preclinical CRO services that are essential for evaluating the safety, efficacy, and pharmacokinetics of drug candidates prior to their progression to clinical trials. Preclinical CROs conduct critical testing to support drug development, ensuring that potential treatments meet necessary regulatory and scientific standards before advancing to human trials.

The global preclinical CRO market was valued at $3,755.82 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Increased Focus On Personalized Medicine

Increased focus on personalized medicine propelled the growth of the preclinical CRO market in the historic period. Personalized medicine frequently requires intricate study designs, including the evaluation of multiple biomarkers or genetic variants. Preclinical CROs possess the expertise needed to manage these complex studies, providing specialized skills in designing and conducting experiments tailored to the specific needs of personalized treatment approaches. For instance, in October 2022, according to the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system) estimated that more than 75,000 genetic testing products and 300 personalized medicines were on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, increased focus on personalized medicine supported the growth of the preclinical CRO market during the historic period.

Innovative CRO Solutions Combine Traditional Services With Cutting-Edge Technology

Companies in the preclinical CRO market are deploying innovative CRO solutions that combine traditional services with cutting-edge technology. This integration optimizes multiple facets of clinical trials, including planning, recruitment, data management and analysis. For instance, in June 2024, Lindus Health, a UK-based clinical research organization, launched an "All-in-One Medical Device CRO" that combines traditional CRO services with unique recruitment capabilities and proprietary eClinical technology. This new offering utilizes a database of over 30 million electronic health records (EHRs) and in-house digital marketing strategies for participant recruitment. It also provides extensive in-house site capabilities, including virtual and hybrid options, as well as a network of physical community sites.

The global preclinical CRO market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up 30.6% of the total market in 2023.

Preclinical CRO Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global preclinical CRO market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for preclinical CRO? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The preclinical CRO market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider preclinical CRO market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by service, by type, by animal model, by model system and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the preclinical CRO market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by service, by type, by animal model, by model system and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for preclinical CRO providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services
  • 2) By Type: Patient-Derived Organoid (PDO) Model; Patient Derived Xenograft Model
  • 3) By Animal Model: Small Animal Model; Large Animal Model
  • 4) By Model System: In Vivo; In Vitro
  • 5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-Users
  • Companies Mentioned: Charles River Laboratories International, Inc.; Thermo Fisher Scientific Inc. (Pharmaceutical Product Development (PPD); Eurofins Scientific SE; Laboratory Corporation of America Holdings (Covance Inc.); ICON Plc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; preclinical CRO indicators comparison
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Preclinical CRO - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Preclinical CRO Market Definition And Segmentations
  • 6.4 Market Segmentation By Service
    • 6.4.1 Bioanalysis And DMPK Studies
    • 6.4.2 Toxicology Testing
    • 6.4.3 Compound Management
    • 6.4.4 Chemistry
    • 6.4.5 Safety Pharmacology
    • 6.4.6 Others Services
  • 6.5 Market Segmentation By Type
    • 6.5.1 Patient-Derived Organoid (PDO) Model
    • 6.5.2 Patient Derived Xenograft Model
  • 6.6 Market Segmentation By Animal Model
    • 6.6.1 Small Animal Model
    • 6.6.2 Large Animal Model
  • 6.7 Market Segmentation By Model System
    • 6.7.1 In Vivo
    • 6.7.2 In Vitro
  • 6.8 Market Segmentation By End User
    • 6.8.1 Biopharmaceutical Companies
    • 6.8.2 Government And Academic Institutes
    • 6.8.3 Medical Device Companies
    • 6.8.4 Other End-users

7 Major Market Trends

  • 7.1 Introduction Of Comprehensive Clinical Trial Services Units For End-To-End Support
  • 7.2 Innovative CRO Solutions Combine Traditional Services With Cutting-Edge Technology
  • 7.3 Accelerating Drug Development Pipelines With Advanced AI Platforms

8 Preclinical CRO Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Preclinical CRO Market
  • 8.2 Impact Of The War In Ukraine On The Preclinical CRO Market
  • 8.3 Impact Of High Inflation On The Preclinical CRO Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Preclinical CRO Market Segmentation

  • 10.1 Global Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Preclinical CRO Market, Segmentation By Animal Model, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Preclinical CRO Market, Segmentation By Model System, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Preclinical CRO Market, Regional and Country Analysis

  • 11.1 Global Preclinical CRO Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Preclinical CRO Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Preclinical CRO Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 UK Market
  • 13.6 UK Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.7 UK Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 Germany Market
  • 13.10 Germany Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 France Market
  • 13.14 France Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 Italy Market
  • 13.18 Italy Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Spain Market
  • 13.22 Spain Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Preclinical CRO Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Preclinical CRO Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Major Companies
  • 16.2 South America Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Preclinical CRO Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Major Companies
  • 17.2 Middle East Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Government Initiatives
    • 18.1.5 Regulations
    • 18.1.6 Regulatory Bodies
    • 18.1.7 Major Associations
    • 18.1.8 Taxes Levied
    • 18.1.9 Corporate Tax Structure
    • 18.1.10 Investments
    • 18.1.11 Major Companies
  • 18.2 Africa Preclinical CRO Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Preclinical CRO Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Preclinical CRO Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Charles River Laboratories International, Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Financial Overview
  • 19.3 Thermo Fisher Scientific Inc. (Pharmaceutical Product Development (PPD)
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Eurofins Scientific SE
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 Laboratory Corporation of America Holdings (Covance Inc.)
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 ICON Plc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Selvita S.A. Acquired PozLab
  • 22.2 Veeda Clinical Research Limited Acquired Heads
  • 22.3 Iuvo Bioscience Acquired Promedica International
  • 22.4 ProPharma Group Acquired Clinres Farmacija
  • 22.5 Alliance Pharmaceuticals Limited Acquired Denali Medpharma
  • 22.6 ETAP-Lab Acquired SYNCROSOME
  • 22.7 ERBC Group Acquired Oncofactory
  • 22.8 Novotech Acquired EastHORN
  • 22.9 BioIVT, LLC Acquired XenoTech, LLC
  • 22.10 Asahi Kasei Medical Co. Ltd Acquired Bionova Scientific LLC
  • 22.11 Altasciences Acquired Sinclair Research
  • 22.12 Thermo Fisher Scientific Inc. Acquired PPD Inc.
  • 22.13 Laboratory Corporation of America Holdings (LabCorp) Acquired Toxikon Corporation

23 Opportunities And Strategies

  • 23.1 Global Preclinical CRO Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Preclinical CRO Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Preclinical CRO Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Preclinical CRO Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer